# Clinical Evaluation of BD NEXT Pen Needle

> **NCT01852136** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 217 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** BD NEXT 31G x 5 mm pen needle
- **DEVICE:** BD NEXT 31G x 8mm pen needle
- **DEVICE:** BD NEXT 32G x 4mm pen needle

## Key facts

- **NCT ID:** NCT01852136
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852136, "Clinical Evaluation of BD NEXT Pen Needle". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01852136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*